# Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant

> **NCT01502267** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 2 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** High dose IVIG and B cell depleting agents

## Key facts

- **NCT ID:** NCT01502267
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2014-01
- **Final completion:** 2016-01
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2012-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01502267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01502267, "Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01502267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*